Barr Tries To Cut Generic Market By Entering It

Law360, New York (September 8, 2006, 12:00 AM EDT) -- Barr Pharmaceuticals Inc. is launching a generic of a subsidiary’s birth control drug, Seasonale, after a rival won U.S. Food and Drug Administration approval of a generic equivalent.

Watson Pharmaceuticals filed an Abbreviated New Drug Application for levonorgestrel/ethinyl estradioal tablets following expiration of Barr’s product exclusivity earlier this month.

"While issues related to our application with the Patent and Trademark Office to reissue the patent covering Seasonale are being resolved, we will take those steps appropriate to defend our interests in this proprietary product," said Bruce...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.